Package Leaflet: Information for the User
Rivaroxaban Aristo 10 mg film-coated tablets EFG
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Rivaroxaban contains the active substance rivaroxaban and is used in adults to:
Rivaroxaban belongs to a group of medications called antithrombotic agents. It works by blocking a clotting factor (factor Xa) and thus reducing the tendency of blood to form clots.
Do not take Rivaroxaban
Do not take Rivaroxaban and inform your doctorif any of these circumstances apply to your case.
Warnings and precautions
Consult your doctor or pharmacist before starting to take rivaroxaban.
Be careful with Rivaroxaban
Tell your doctorif you have any of these situationsbefore taking Rivaroxaban. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
If you need surgery:
Children and adolescents
Rivaroxaban Aristo 10 mg tablets are not recommended for children under 18 years of age.There is not enough information about its use in children and adolescents.
Other medications and Rivaroxaban
Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medication, including those obtained without a prescription.
If any of the above circumstances apply to you,tell your doctorbefore taking rivaroxaban, as the effect of rivaroxaban may increase. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
If your doctor considers that you have a higher risk of developing stomach or intestinal ulcers, they will recommend using a preventive treatment for ulcers in addition to rivaroxaban.
If any of the above circumstances apply to you, tell your doctorbefore taking rivaroxaban, as the effect of rivaroxaban may be reduced. Your doctor will decide if you should be treated with rivaroxaban and if you should be kept under closer observation.
Pregnancy and breastfeeding
Do not take rivaroxaban if you are pregnant or breastfeeding. If there is any possibility that you may become pregnant, use a reliable contraceptive while taking rivaroxaban. If you become pregnant while taking this medication, tell your doctor immediately, who will decide how you should be treated.
Driving and using machines
Rivaroxaban may cause dizziness (frequent side effect) or fainting (uncommon side effect) (see section 4, "Possible side effects"). You should not drive, ride a bicycle, or use tools or machines if you are affected by these symptoms.
Rivaroxaban contains lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Rivaroxaban contains sodium
This medication contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially "sodium-free".
Follow the instructions for administration of this medication indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
What doseto take
The recommended dose is one rivaroxaban 10 mg tablet once a day.
After at least 6 months of treatment for blood clots, the recommended dose is one 10 mg tablet once a day or one 20 mg tablet once a day. Your doctor has prescribed rivaroxaban 10 mg once a day.
Swallow the tablet, preferably with water.
Rivaroxaban can be taken with or without food.
If you have difficulty swallowing the whole tablet, consult your doctor about other ways to take rivaroxaban. The tablet can be crushed and mixed with water or apple puree, immediately before taking it.
If necessary, your doctor can also administer the crushed rivaroxaban tablet through a gastric tube.
When to take Rivaroxaban
Take one tablet every day, until your doctor tells you to stop.
Try to take one tablet at the same time every day, to help you remember.
Your doctor will decide how long you should continue taking the treatment.
To prevent the formation of blood clots in the veins after hip or knee replacement surgery:
Take the first tablet 6 to 10 hours after surgery.
If you have undergone major hip surgery, you will usually take tablets for 5 weeks.
If you have undergone major knee surgery, you will usually take tablets for 2 weeks.
If you take more Rivaroxaban than you should
Call your doctor immediately if you have taken too many rivaroxaban tablets. Taking too much rivaroxaban increases the risk of bleeding.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Rivaroxaban
If you forget to take a dose, take it as soon as you remember. Take the next tablet the next day and, after that, take one tablet every day, as usual.
Do not take a double dose to make up for forgotten doses.
If you stop taking Rivaroxaban
Do not stop taking rivaroxaban without talking to your doctor first, as rivaroxaban prevents the development of a serious condition.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, rivaroxaban can cause side effects, although not everyone gets them.
Like other similar medications to reduce blood clot formation, rivaroxaban can cause bleeding, which can be life-threatening. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be apparent.
Tell your doctor immediately if you experience any of the following side effects:
Your doctor will decide to keep you under closer observation or modify your treatment.
The frequency of this side effect is very rare (up to 1 in 10,000).
The frequencies of these side effects are very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).
General list of possible side effects:
Frequent(may affect up to 1 in 10 patients):
Uncommon(may affect up to 1 in 100 patients):
Rare(may affect up to 1 in 1,000 patients):
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(cannot be estimated from available data):
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are possible side effects not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on each blister after “EXP”. The expiry date refers to the last day of the month indicated.
This medicine does not require any special storage conditions.
Crushed tablets
Crushed tablets are stable in water or apple sauce for up to 2 hours.
Medicines should not be disposed of via wastewater or household waste. Return all unused medicines to your pharmacist, or take them to a designated collection point (SIGRE point) in your pharmacy. Ask your pharmacist how to dispose of medicines no longer required. This will help to protect the environment.
Composition of Rivaroxaban Aristo
Tablet core: microcrystalline cellulose, sodium croscarmellose, lactose monohydrate, hypromellose 2910, sodium laurilsulfate, magnesium stearate. See section 2 “Rivaroxaban Aristo contains lactose and sodium”.
Tablet film coating: hypromellose 2910, titanium dioxide (E 171), macrogol 3350, red iron oxide (E 172).
Appearance and package contents
Rivaroxaban Aristo 10 mg film-coated tablets are pink, round, biconvex (6 mm in diameter) and engraved with “10” on one side, and smooth on the other.
They are available in transparent PVC/PVDC aluminium blisters in cardboard boxes.
Boxes of 5, 7, 10, 14, 28, 30, 42, 45, 56, 98 or 100 film-coated tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder
Aristo Pharma GmbH
Wallenroder Straße 8-10
13435 Berlin
Germany
Manufacturer
S.C. Labormed-Pharma S.A.
Bd. Theodor Pallady nr. 44B, sector 3
Bucharest cod 032266
Romania
Or
Saneca Pharmaceuticals a.s.
Nitrianska 100
920 27 Hlohovec
Slovakia
For further information about this medicine, please contact the local representative of the marketing authorisation holder:
Aristo Pharma Iberia, S.L.
C/ Solana, 26
28850, Torrejón de Ardoz
Madrid, Spain
This medicine is authorised in the Member States of the EEA and in the United Kingdom (Northern Ireland) under the following names:
Austria Rivaroxaban Aristo 10 mg Filmtabletten
Italy Rivaroxaban Aristo
Norway Rivaroxaban Aristo 10 mg film-coated tablets
Spain Rivaroxaban Aristo 10 mg film-coated tablets EFG
Sweden Rivaroxaban Aristo 10 mg film-coated tablets
Portugal Rivaroxaban Aristo
Denmark Rivaroxaban Aristo
Germany Rivaroxaban Aristo 10 mg Filmtabletten
United Kingdom Rivaroxaban
(Northern Ireland)
Date of last revision of this leaflet:January 2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/